Search Results - "MATAKI, Y"

Refine Results
  1. 1
  2. 2

    A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study by Motoi, Fuyuhiko, Satoi, Sohei, Honda, Goro, Wada, Keita, Shinchi, Hiroyuki, Matsumoto, Ippei, Sho, Masayuki, Tsuchida, Akihiko, Unno, Michiaki

    Published in Journal of gastroenterology (01-02-2019)
    “…Background Neoadjuvant chemotherapy (NAC) represents a promising alternative to pancreatic ductal adenocarcinoma (PDAC) planned resection, but the survival…”
    Get full text
    Journal Article
  3. 3

    CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer by Maeda, S, Shinchi, H, Kurahara, H, Mataki, Y, Maemura, K, Sato, M, Natsugoe, S, Aikou, T, Takao, S

    Published in British journal of cancer (22-04-2008)
    “…Although CD133 has been shown to be a marker for cancer stem cells in various tumours, its expression in pancreatic cancer has not yet been clinically…”
    Get full text
    Journal Article
  4. 4

    Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer by Arigami, T, Natsugoe, S, Uenosono, Y, Arima, H, Mataki, Y, Ehi, K, Yanagida, S, Ishigami, S, Hokita, S, Aikou, T

    Published in British journal of cancer (19-09-2005)
    “…The monoclonal antibody D2-40 is a specific lymphatic endothelial markers and D2-40 staining have been applicable to evaluate lymphatic invasion in various…”
    Get full text
    Journal Article
  5. 5

    Clinical significance of midkine expression in pancreatic head carcinoma by MAEDA, S, SHINCHI, H, TAKAO, S, KURAHARA, H, MATAKI, Y, NOMA, H, MAEMURA, K, ARIDOME, K, YOKOMINE, T, NATSUGOE, S, AIKOU, T

    Published in British journal of cancer (06-08-2007)
    “…Midkine (MK) is a heparin-binding growth factor and a product of a retinoic acid-responsive gene. Midkine is overexpressed in many carcinomas and thought to…”
    Get full text
    Journal Article
  6. 6

    The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma by OKUMURA, H, NATSUGOE, S, MATSUMOTO, M, MATAKI, Y, TAKATORI, H, ISHIGAMI, S, TAKAO, S, AIKOU, T

    Published in British journal of cancer (31-01-2005)
    “…The p53 family regulates cell-cycle arrest, triggers apoptosis or is involved in repair of DNA damage. In the present study, we analysed the expression of some…”
    Get full text
    Journal Article
  7. 7

    Phase-I trial of oral fluoropyrimidine anticancer agent (S-1) with concurrent radiotherapy in patients with unresectable pancreatic cancer by SHINCHI, H, MAEMURA, K, NOMA, H, MATAKI, Y, AIKOU, T, TAKAO, S

    Published in British journal of cancer (07-05-2007)
    “…In this phase-I trial, we evaluated the safety of S-1, a novel oral fluoropyrimidine anticancer agent, combined with external-beam radiotherapy (EBRT) to…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Role of thymidine phosphorylase in Fas-induced apoptosis by Mori, S, Takao, S, Ikeda, R, Noma, H, Mataki, Y, Wang, X, Akiyama, S, Aiko, T

    “…Thymidine phosphorylase (TP) has chemotactic and angiogenic activity in vitro, and it promotes tumor growth and inhibits apoptosis in vivo. It plays a key role…”
    Get more information
    Journal Article
  18. 18

    Robotic rehabilitation training with a newly developed upper limb single-joint hybrid assistive limb (HAL-SJ) for an adult with birth palsy by Kubota, S., Yoshikawa, K., Takeuchi, R., Endo, Y., Sano, A., Koseki, K., Mataki, Y., Iwasaki, N., Kohno, Y., Mutsuzaki, H.

    “…The birth palsy is a peripheral nerve palsy resulting in disturbance in activities of daily living (ADL), and it occurs the co-contracture due to nerve…”
    Get full text
    Journal Article
  19. 19
  20. 20